Interleukin-1 receptor antagonist gene polymorphism in patients with multidrug-resistant Acinetobacter baumannii-associated pneumonia
Objective: Multidrug-resistant Acinetobacter baumannii (MDRAB)-associated pneumonia has been a common disease and a therapeutic problem in hospitals. Interleukin-1 receptor antagonist (IL-1ra) has been considered a required role for host immune defense in pneumonia disease. The aim of this study was...
Main Authors: | Min-Jer Hsu, Yun-Chieh Lu, Yu-Chang Hsu, Wen-Sheng Liu, Wen-Tung Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Annals of Thoracic Medicine |
Subjects: | |
Online Access: | http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2012;volume=7;issue=2;spage=74;epage=77;aulast=Hsu |
Similar Items
-
The immune response in Acinetobacter baumannii pneumonia
by: Cristina Anca Tudor, et al.
Published: (2016-03-01) -
Management of necrotizing pneumonia with bronchopleural fistula caused by multidrug‐resistant Acinetobacter baumannii
by: Allen Widysanto, et al.
Published: (2020-11-01) -
Community-acquired Acinetobacter baumannii pneumonia: a rare case in Brazil
by: Izadora Raduan Brigo, et al.
Published: (2022-11-01) -
Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia
by: Yanling Deng, et al.
Published: (2022-10-01) -
Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
by: Yangang Zhou, et al.
Published: (2019-04-01)